Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 188 entries
View as:

An Observational Study of the Prevalence of Patients Requiring Palliative Care in French Anti-cancer Centers.

Phase: N/A Priority: Normal
NCT ID: NCT02479061 Org: User:
Start: 06/30/15 End: 06/30/17 Due: 06/30/18

A Clinical and Biological Umbrella Protocol for Smoker or Non-smoker Patients With OPML or HNSCC

Phase: N/A Priority: Normal
NCT ID: NCT03276819 Org: User:
Start: 02/01/18 End: 07/31/20 Due: 07/31/21

A Retro-/Prospective, Non-interventional, Cohort Study in Adult Patients With Locally Advanced or Metastatic Tumors With a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion, Treated With Larotrectinib

Phase: N/A Priority: Normal
NCT ID: NCT04814667 Org: User:
Start: 02/23/21 End: 09/15/24 Due: 09/15/25

Phase I/II Study Evaluating PSMA Targeted Radionuclide Therapy in Adult Patients with Metastatic Clear Cell Renal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06059014 Org: User:
Start: 11/09/23 End: 04/30/26 Due: 04/30/27

Satisfaction & Efficacy of Compression Using Surgical Gloves in Chemo-induced Peripheral Neuropathies

Phase: N/A Priority: Normal
NCT ID: NCT03872908 Org: User:
Start: 09/29/19 End: 02/29/24 Due: 02/28/25

Tumor and Treatments Impact on Neurocognitive Functions and Quality of Life of Patients With OMS Grade II Glioma

Phase: N/A Priority: Normal
NCT ID: NCT01305122 Org: User:
Start: 02/28/11 End: 10/21/18 Due: 10/21/19

Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT03967522 Org: User:
Start: 11/29/19 End: 11/01/24 Due: 11/01/25

Study of Impact of Routine "Clinical Cancer Department/Supportive Care Department" Consultation on the Prescription of an Additional Line of Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00905281 Org: User:
Start: 11/30/08 End: 06/30/14 Due: 06/30/15

A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.

Phase: N/A Priority: Normal
NCT ID: NCT04671693 Org: User:
Start: 12/24/20 End: 04/24/28 Due: 04/24/29

Assessment of the Reasons for Accepting or Refusing Early Palliative Care

Phase: N/A Priority: Normal
NCT ID: NCT04717440 Org: User:
Start: 02/04/21 End: 03/22/23 Due: 03/22/24

Contribution of Multicenter Expertise and Deformable Fusion Software for Re-irradiations With Curative Intent

Phase: N/A Priority: Normal
NCT ID: NCT06668038 Org: User:
Start: 11/01/24 End: 02/01/29 Due: 02/01/30

Prospective Multicentric Randomized Study of Glivec® in Advanced GIST Expressing C-kit: Interruption After 5 Years vs Maintenance

Phase: N/A Priority: Normal
NCT ID: NCT00367861 Org: User:
Start: 05/31/02 End: 05/31/13 Due: 05/31/14

Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive

Phase: N/A Priority: Normal
NCT ID: NCT01737450 Org: User:
Start: 01/31/13 End: 03/31/19 Due: 03/31/20

Parental Perception of Their Child's Emotional Quality of Life in Paediatric Oncology Before and After "Magic Massages"

Phase: N/A Priority: Normal
NCT ID: NCT06107478 Org: User:
Start: 10/31/23 End: 01/31/25 Due: 01/31/26

Assessing the Ompact of Neutral Pelvic Positioning on Bone Repositioning Quality in Pelvic Radiotherapy Patients

Phase: N/A Priority: Normal
NCT ID: NCT06687200 Org: User:
Start: 11/15/24 End: 03/01/27 Due: 03/01/28

Axillary Sentinel Lymph Node Detection in Breast Cancers > 2 cm

Phase: N/A Priority: Normal
NCT ID: NCT00636467 Org: User:
Start: 03/31/08 End: 09/30/11 Due: 09/30/12

Evaluation of Efficacy and Safety De-escalation Versus Standard Adjuvant Chemotherapy in Patients With Low Risk Localized Gastroesophageal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06933966 Org: User:
Start: 09/01/25 End: 09/01/32 Due: 09/01/33

Cicaderma Efficacy vs Standard Care of Sites in Preventing Radiodermatitis in Non-metastatic Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT04300829 Org: User:
Start: 06/06/20 End: 10/09/22 Due: 10/09/23

Study of the Efficacy of SBRT on Unresectable Peripheral Primary Tumor

Phase: N/A Priority: Normal
NCT ID: NCT02400424 Org: User:
Start: 02/28/15 End: 06/25/20 Due: 06/25/21

RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions.

Phase: N/A Priority: Normal
NCT ID: NCT03375437 Org: User:
Start: 02/15/18 End: 12/15/25 Due: 12/15/26

Evaluation of Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic Cyclophosphamide

Phase: N/A Priority: Normal
NCT ID: NCT03139851 Org: User:
Start: 06/27/17 End: 09/18/19 Due: 09/18/20

Phase 2 Study Evaluating Mid-position Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-small Cell Lung Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01635270 Org: User:
Start: 09/12/12 End: 08/31/20 Due: 08/31/21

Lifestyle Intervention After Colonoscopy (LIFE-SCREEN Pilot)

Phase: N/A Priority: Normal
NCT ID: NCT05273931 Org: User:
Start: 03/16/22 End: 12/31/23 Due: 12/31/24

NP137 Clinical and Biological Activities Assessment in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Anti PD-1/PD-L1 Immunotherapies

Phase: N/A Priority: Normal
NCT ID: NCT05605496 Org: User:
Start: 01/06/23 End: 11/24/26 Due: 11/24/27

Study Evaluating the Efficacy of the myDIET Software Tool in the Nutritional Management of Patients With Localized and Resectable Gastric or Esogastric Junction Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT06385691 Org: User:
Start: 04/26/24 End: 08/31/26 Due: 08/31/27